How Mentoring Connections Can Make All the Difference
|
By Jen A. Miller (AACC) Posted on 07 Jul 2023 |

Illustration
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be a destination for clinical laboratorians and those interested in the field from all walks of life, including young professionals. For this group, AACC has included two key events: the Society for Young Clinical Laboratorians (SYCL) Workshop and Mixer on Saturday, and the Careers in Industry 2023: Impact Patient Care through Industry luncheon and panel discussion on Sunday.
Both of these events are designed to help early career professionals find their footing, including those who are new to the field and curious about different approaches to their career opportunities.
The Careers in Industry event, hosted by AACC’s Corporate Advisory Board (CAB) and SYCL, “offers different pathways for laboratorians in all disciplines and degrees to support healthcare, even if it’s not directly inside of a hospital,” said LaShanta Brice, DCLS, MLS (ASCP)SH, scientific engagement and clinical education associate at Stago, and who was a panelist during last year’s Careers in Industry luncheon. The event features leaders working at top diagnostic companies with diverse sets of backgrounds sharing their career paths, expertise, and experiences, followed by a Q&A portion and time for networking.
The Careers in Industry panelists will be a mix of beginning, middle, and advanced career laboratorians, which means young attendees coming to this interactive session will get a “good mix of professionals so you can see a pathway in front of you,” she added.
Brice earned a clinical doctorate in clinical laboratory science which she said is a fairly new degree. The path ahead of her was less clear than if she’d taken a more traditional laboratory medicine route. “One of the challenges was trying to find a group of people that I could talk to, and who could potentially be my advisors outside of the hospital,” she said. She found that both SYCL and the CAB were “great places for me to get connected” with the industry side of laboratory medicine.
For 10 years, including the time she worked on her doctorate degree, she worked at the Brook Army Medical Center, starting as a lead hematology medical laboratory scientist and rising to hematology supervisor. There, she was given a military coin from the chief of medicine—a rare honor for a civilian, and a career highlight, she said.
Looking for a new challenge, and with a doctoral degree in hand, she moved to Stago, and into project management. The connections she made, and mentorship she found, at AACC have helped her make the transition from the bench into scientific affairs and project management. It wasn’t easy at first. “I was so used to firefighting that I didn’t land very well with long term projects. I tended to finish projects like I was Sonic the Hedgehog,” she joked.
But AACC helped. “Now I have to make connections to different groups outside of the laboratory as opposed to working on issues within four walls,” she said. Through mentorships, she learned she didn’t need to rush all the time, and to slow down. In doing so, she has been able to focus on working outside the laboratory with multiple sets of clinicians.
Brice is looking forward to meeting new young professionals at the meeting this year and helping them make the same links, especially for those interested in industry work. “SYCL is the best way for you to connect with AACC if you’re looking to dip your toes into the water and find someone you can partner with as you journey through the process,” she said.
SYCL can also help first time attendees navigate a conference that has returned to full, in-person size since the COVID-19 pandemic. “If this is your first time to AACC, it’s quite overwhelming. The expo floor is gigantic. There are so many scientific sessions, and it can feel daunting if you don’t have a way to find out information and connect with people that are like minded,” she said.
Both of these events are designed to help early career professionals find their footing, including those who are new to the field and curious about different approaches to their career opportunities.
The Careers in Industry event, hosted by AACC’s Corporate Advisory Board (CAB) and SYCL, “offers different pathways for laboratorians in all disciplines and degrees to support healthcare, even if it’s not directly inside of a hospital,” said LaShanta Brice, DCLS, MLS (ASCP)SH, scientific engagement and clinical education associate at Stago, and who was a panelist during last year’s Careers in Industry luncheon. The event features leaders working at top diagnostic companies with diverse sets of backgrounds sharing their career paths, expertise, and experiences, followed by a Q&A portion and time for networking.
The Careers in Industry panelists will be a mix of beginning, middle, and advanced career laboratorians, which means young attendees coming to this interactive session will get a “good mix of professionals so you can see a pathway in front of you,” she added.
Brice earned a clinical doctorate in clinical laboratory science which she said is a fairly new degree. The path ahead of her was less clear than if she’d taken a more traditional laboratory medicine route. “One of the challenges was trying to find a group of people that I could talk to, and who could potentially be my advisors outside of the hospital,” she said. She found that both SYCL and the CAB were “great places for me to get connected” with the industry side of laboratory medicine.
For 10 years, including the time she worked on her doctorate degree, she worked at the Brook Army Medical Center, starting as a lead hematology medical laboratory scientist and rising to hematology supervisor. There, she was given a military coin from the chief of medicine—a rare honor for a civilian, and a career highlight, she said.
Looking for a new challenge, and with a doctoral degree in hand, she moved to Stago, and into project management. The connections she made, and mentorship she found, at AACC have helped her make the transition from the bench into scientific affairs and project management. It wasn’t easy at first. “I was so used to firefighting that I didn’t land very well with long term projects. I tended to finish projects like I was Sonic the Hedgehog,” she joked.
But AACC helped. “Now I have to make connections to different groups outside of the laboratory as opposed to working on issues within four walls,” she said. Through mentorships, she learned she didn’t need to rush all the time, and to slow down. In doing so, she has been able to focus on working outside the laboratory with multiple sets of clinicians.
Brice is looking forward to meeting new young professionals at the meeting this year and helping them make the same links, especially for those interested in industry work. “SYCL is the best way for you to connect with AACC if you’re looking to dip your toes into the water and find someone you can partner with as you journey through the process,” she said.
SYCL can also help first time attendees navigate a conference that has returned to full, in-person size since the COVID-19 pandemic. “If this is your first time to AACC, it’s quite overwhelming. The expo floor is gigantic. There are so many scientific sessions, and it can feel daunting if you don’t have a way to find out information and connect with people that are like minded,” she said.
Latest AACC 2023 News
- First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award
- Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023
- Laboratory Experts Show How They Are Leading the Way on Global Trends
- Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors
- Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023
- Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections
- New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs
- AI Predicts Multiple Sclerosis Risk, Flags Potentially Contaminated Lab Results
- Scientific Session Explores Role of Technology in New Era of Specimen Transport
- Prevencio Presents AI-Driven Platform for Medical Diagnostic Test Development
- Scientific Session Explores Future Role of AI and ML in Clinical Laboratory
- SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs
- World's First Large Sample Volume, Open-Assay, Super-fast, Ultra-Sensitive, and Sample-To-Answer PCR Instrument
- Vital Biosciences Unveils Revolutionary POC Lab Testing Platform
- World's Smallest POC Device for Complete Blood Count in 30 Minutes Unveiled
- General Biologicals Unveils CTC Cancer Detection Products and Automated Molecular System
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








